Resmed Inc. buy JPMorgan Chase & Co.
Start price
15.04.26
/
50%
€194.25
Target price
15.04.27
-
Performance (%)
-0.39%
Price
04.08.26
€193.50
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by -0.39%. This prediction currently runs until 15.04.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 5.421% | 5.421% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat